【正文】 1~253目前, 基因治療已擴(kuò)大到腫瘤、心血管系統(tǒng)疾病、神經(jīng)系統(tǒng)疾病等的治療[12]。目前已用克隆表達(dá)VHb的方法提高了放線紫紅素、頭孢霉素C、紅霉素等產(chǎn)生菌及青霉素酰化酶基因工程菌的產(chǎn)量[10]。為治愈癌癥正在研制的用單克隆抗體制成的“生物導(dǎo)彈”, 就是按照人類的設(shè)計(jì), 把“生物導(dǎo)彈”發(fā)射出去, 精確的命中癌細(xì)胞, 并炸死癌細(xì)胞, 而不傷害健康的細(xì)胞, 比如專門用于腫瘤的“腫瘤基因?qū)棥钡取?基因工程研究內(nèi)容(1) 從復(fù)雜的生物有機(jī)體基因組中, 經(jīng)過酶切消化或PCR 擴(kuò)增等步驟, 分離出帶有目的基因的DNA 片段。 應(yīng)用現(xiàn)狀 Shallow gene engineering technology application statusStudent majoring in Veterinary Medicine YinxunqiangTutor MinlingjiangAbstract: Genetic engineering as a door the theory with practical strong subject, the method and technology has penetrated into the modern life science of each branch, bee life science and a core technology. Genetic engineering contains many unique experiment method and technique, not only rich content, broad and practical also strong. gene engineering is obtained through DNA rebinant technology, with special biological genetics and function of the genetic tools organisms, genetic engineering technology, widely used in agriculture, medicine, food industry etc. This paper genetic engineering application status of prehensive elaboration.Key words: gene engineering, DNA rebinant technology,Application status 基因工